355 related articles for article (PubMed ID: 18511546)
21. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis.
Thompson AE; Pope JE
J Rheumatol; 2002 Sep; 29(9):1867-73. PubMed ID: 12233880
[TBL] [Abstract][Full Text] [Related]
22. Geoepidemiology of systemic sclerosis.
Ranque B; Mouthon L
Autoimmun Rev; 2010 Mar; 9(5):A311-8. PubMed ID: 19906362
[TBL] [Abstract][Full Text] [Related]
23. The relationship of dyspnoea to function and quality of life in systemic sclerosis.
Baron M; Sutton E; Hudson M; Thombs B; Markland J; Pope J; Robinson D; Jones N; Docherty P; Abu-Hakima M; LeClercq S; Smith D; Mathieu JP
Ann Rheum Dis; 2008 May; 67(5):644-50. PubMed ID: 17728334
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
[TBL] [Abstract][Full Text] [Related]
25. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
van Loon RL; Roofthooft MT; Hillege HL; ten Harkel AD; van Osch-Gevers M; Delhaas T; Kapusta L; Strengers JL; Rammeloo L; Clur SA; Mulder BJ; Berger RM
Circulation; 2011 Oct; 124(16):1755-64. PubMed ID: 21947294
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary arterial hypertension in systemic sclerosis.
Lambova S; Müller-Ladner U
Autoimmun Rev; 2010 Sep; 9(11):761-70. PubMed ID: 20601197
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of sicca symptoms in a South Australian cohort with systemic sclerosis.
Swaminathan S; Goldblatt F; Dugar M; Gordon TP; Roberts-Thomson PJ;
Intern Med J; 2008 Dec; 38(12):897-903. PubMed ID: 18422567
[TBL] [Abstract][Full Text] [Related]
28. [Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: diagnostic approach of a single center].
Kayikçioğlu M; Kültürsay H
Anadolu Kardiyol Derg; 2008 Aug; 8(4):279-85. PubMed ID: 18676304
[TBL] [Abstract][Full Text] [Related]
29. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
30. Scleroderma prevalence: demographic variations in a population-based sample.
Bernatsky S; Joseph L; Pineau CA; Belisle P; Hudson M; Clarke AE
Arthritis Rheum; 2009 Mar; 61(3):400-4. PubMed ID: 19248123
[TBL] [Abstract][Full Text] [Related]
31. Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis.
Kowal-Bielecka O; Delcroix M; Vonk-Noordegraaf A; Hoeper MM; Naeije R
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v39-41. PubMed ID: 18784140
[TBL] [Abstract][Full Text] [Related]
32. Increased serum interleukin 23 in patients with systemic sclerosis.
Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
[TBL] [Abstract][Full Text] [Related]
33. Relationship between parity and clinical and biological features in patients with systemic sclerosis.
Launay D; Hebbar M; Hatron PY; Michon-Pasturel U; Queyrel V; Hachulla E; Devulder B
J Rheumatol; 2001 Mar; 28(3):509-13. PubMed ID: 11296950
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary arterial hypertension complicating connective tissue diseases.
Hassoun PM
Semin Respir Crit Care Med; 2009 Aug; 30(4):429-39. PubMed ID: 19634082
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
Proudman SM; Stevens WM; Sahhar J; Celermajer D
Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726
[TBL] [Abstract][Full Text] [Related]
36. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Usui A; Hasegawa M; Fujimoto M; Takehara K; Sato S
J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
Vemulapalli S; Cohen L; Hsu V
Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary hypertension in systemic sclerosis.
Chatterjee S
Semin Arthritis Rheum; 2011 Aug; 41(1):19-37. PubMed ID: 21047671
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic.
Jansa P; Becvar R; Ambroz D; Palecek T; Tomcik M; Skacelova S; Aschermann M; Linhart A
Clin Rheumatol; 2012 Mar; 31(3):557-61. PubMed ID: 22105781
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of systemic sclerosis in a French multi-ethnic county.
Le Guern V; Mahr A; Mouthon L; Jeanneret D; Carzon M; Guillevin L
Rheumatology (Oxford); 2004 Sep; 43(9):1129-37. PubMed ID: 15213329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
